Trial intelligence / Profile preview

Fospropofol Disodium Injection vs Propofol for General Anesthesia in Elective Surgery

ChiCTR2500095331Phase 4Not yet recruiting

Sponsor
Dalian Third People's Hospital
Start
Jan 2025
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of fospropofol disodium in rhinosinusitis (2 arms), sponsored by Dalian Third People's Hospital. Primary endpoint: Changes in hemodynamic indices and BIS values at multiple time points. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

fospropofol disodium
03

Conditions

rhinosinusitis

Beyond the preview

Go deeper on ChiCTR2500095331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500095331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call